Activated DCs secrete inflammatory cytokines, such as IFN‐γ and IL‐12, which in turn activate adaptive immune cells, including CD8+ T‐cells, to target and eliminate tumor cells [5, 29, 30]. This evidence concerns the gene CD8A and neoplasm.